摘要
目的:比较经导管三种国产封堵器治疗继发孔型房间隔缺损(ASD)的疗效和并发症。方法:采用相同的入选标准,从2001年在我院接受治疗的继发孔型ASD患者,选择符合条件的患者共338例。上海记忆新材料有限公司组(简称上海组ASD)113(男41,女72)例;深圳先健医疗器械公司(简称深圳组ASD)113(男40,女73)例;北京华医圣杰医疗器械公司(简称北京组ASD)112(男39,女73)例。3组介入治疗组年龄分别为25±18,24±17和24±16岁(P>0.05);ASD大小分别为19±7,18±5和18±7mm(P>0.05)。3组中各有1例患者既往有阵发性心房颤动病史,各有2例患者为多孔型。结果:全组无死亡。3组国产封堵器在入选标准相同的条件下,技术成功率、主要并发症(包括死亡及封堵器脱落和中风等)、主要并发症、6月右室舒张末期内径(RVEDD)下降比率、操作时间(分)、残余分流、平均住院天数、平均花费等评价指标方面3组均无差别(P>0.05).结论:3种国产封堵器治疗继发孔型房间隔缺损(ASD)的疗效相近,并发症无差别.
AIM: To compare effectiveness, complications, and cost of three domestic-made ASD occluder in atrial septal defect (ASD) closure. METHODS: We prospectively compared closure rates, complication rates, regression of right ventricular dilatation, cost, inpatient stay in 338 patients with secundum atrial septal defects by three domestic-made ASD occluder: 113 cases (25±18 years) were treated shanghai-made occluder, 113 cases(24±17 years) were treated by shenzhen-made ASD septal occluder and 112 cases(24±16 years) were treated by beijing-made ASD septal occluder . RESULTS: There was no death cases in three groups.there was no difference in technical success rate, cardiac complications, regression of right ventricular dilatation by six months, hospital stay, median cost among three groups. CONSLUSION: Transcatheter closure of secundum atrial septal defects with the three domestic-made ASD occluder device was similar in effectiveness, complications, and cost.
出处
《心脏杂志》
CAS
2005年第3期263-264,共2页
Chinese Heart Journal
